![H. Hogan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
H. Hogan
Direttore/Membro del Consiglio presso
METACRINE, INC.
Profilo
H.
Michael Hogan currently works at Otonomy, Inc., as Director from 2023 and Metacrine, Inc., as Director from 2023.
Mr. Hogan also formerly worked at Nabriva Therapeutics Plc, as Chief Executive Officer and Armanino LLP (United States), as Partner.
Mr. Hogan received his undergraduate degree from Colgate University.
Posizioni attive di H. Hogan
| Società | Posizione | Inizio |
|---|---|---|
| METACRINE, INC. | Direttore/Membro del Consiglio | 23/03/2023 |
| OTONOMY | Direttore/Membro del Consiglio | 15/02/2023 |
Precedenti posizioni note di H. Hogan
| Società | Posizione | Fine |
|---|---|---|
Armanino LLP (United States)
 Armanino LLP (United States) Miscellaneous Commercial ServicesCommercial Services Operates as an accounting and consulting firm | Corporate Officer/Principal | - |
| NABRIVA THERAPEUTICS PLC | Amministratore Delegato | - |
Formazione di H. Hogan
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
20
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Colgate University
 Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Armanino LLP (United States)
Armanino LLP (United States) Miscellaneous Commercial ServicesCommercial Services Operates as an accounting and consulting firm | Commercial Services |
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurology diseases | Health Technology |
Metacrine, Inc.
 Metacrine, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in discovery and development of therapies for patients with liver and gastrointestinal diseases | Health Technology |
Nabriva Therapeutics Plc
 Nabriva Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the research, development, and commercialization of novel anti-infective agents | Health Technology |
